Toxin detection as close as an inkj...(apers are expected to be extremely usefu...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Toxin detection as close as an inkjet printer
Date:8/14/2009
apers are expected to be extremely useful in monitoring environmental and food-based toxins, as well as in remote settings in less industrialized countries where simple bioassays are essential for the first stages of detecting disease.
Applications for bioactive paper also include clinical applications in neuroscience, drug assessment, and pharmaceutical development.
'/>"/>
| Contact: Gene Nakonechny genen@mcmaster.ca 905-525-9140 x26781 McMaster University Source:Eurekalert |
Related biology technology :
1. Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin
2. PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting
3. Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
4. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
5. Spectrals EAA(TM) to be used in Phase III study for a sepsis anti-endotoxin therapy
6. New Online Learning Tool Fills the Knowledge Gap on Botulinum Toxin Type B for Cervical Dystonia
7. New designer toxins kill Bt-resistant insect pests
8. Abbott HIV Test Demonstrates Earlier Disease Detection
9. febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment
10. EyeIC Receives FDA 510(k) Clearance for MatchedFlicker(TM) Retinal Aid Detection Technology
11. BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
Post Your Comments:
Related Image:
 Toxin detection as close as an inkjet printer |
(Date:11/24/2009)...f.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Na...elopingandcommercializingnovelpainmanagementtherap...hiefExecutiveOfficer,isscheduledtopresentatthe21st...ember1-2,2009atTheNewYorkPalaceHotelinNewYork,NewY...ncialOfficer,willbeavailabletorespondtoquestionsdu...
(Date:11/24/2009)...4/PRNewswire/--BlueMarbleEnergyCorp.announcedtoday...ty(OPDA)wererecentlyawarded$2millionbyWashingtonSt...private/publicpartnershiptoconstructthestate,sfirs.... ,, "Thisinvestmentwillsignificantlyspeedthede...LincolnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie...
(Date:11/24/2009)...cyendpointhasbeenmetforpatientswithadvanced-stage,...v.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NAS...ceuticalcompanyfocusedonendocrinetherapyandoncolog...dywithitstargetedcytotoxicpeptideconjugate,AEZS-10...tendometrialcancer.Inapersonalizedhealthcareapproa...
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASD...pany,today,announcedthatithassubmittedaMAAtotheEur...ny,senzymereplacementtherapyindevelopment,forthetr...ng,applicationforvelaglucerasealfathathasbeensubmi...anada. , Basedonaglobalsupplyshortageofthecur...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3[0] NeurogesX to Present at Piper Jaffray Health Care Conference[0] Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board[0] AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer[0] Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
...ORONTO, Jan. 29 /PRNewswire-FirstCall/ - ARIUS Res...scovering and developing the next wave of,antibody...perational,results for the fourth quarter and fisc...as a critical year in our development, highlighted...re-IND programs for our lead drug,candidates, our ...
... CHAMPAIGN, Ill. Carbon nanotubes have a sound f... who built the worlds first all-nanotube transisto...ch nanotube devices provide all of the active func...t steps toward the practical implementation of car...tronics and other related applications, said John ...
..., Troy, N.Y. Researchers at Rensselaer Polytechn...new inexpensive, quick-drying polymer that could l...in semiconductor manufacturing and computer chip p...nce and cost savings for conventional photolithogr...poxy siloxane (PES), should also enable a new gene...
Other Biology Technology:ARIUS announces fourth quarter and year-end fiscal 2007 financial results 2ARIUS announces fourth quarter and year-end fiscal 2007 financial results 3ARIUS announces fourth quarter and year-end fiscal 2007 financial results 4ARIUS announces fourth quarter and year-end fiscal 2007 financial results 5ARIUS announces fourth quarter and year-end fiscal 2007 financial results 6ARIUS announces fourth quarter and year-end fiscal 2007 financial results 7ARIUS announces fourth quarter and year-end fiscal 2007 financial results 8ARIUS announces fourth quarter and year-end fiscal 2007 financial results 9ARIUS announces fourth quarter and year-end fiscal 2007 financial results 10ARIUS announces fourth quarter and year-end fiscal 2007 financial results 11ARIUS announces fourth quarter and year-end fiscal 2007 financial results 12ARIUS announces fourth quarter and year-end fiscal 2007 financial results 13New kind of transistor radios shows capability of nanotube technology 2New polymer could improve semiconductor manufacturing, packaging 2(Date:11/23/2009)...community-associated strain of the deadly superbug...st common antibioticsposes a far greater health th...nto hospitals, according to a study in the Decembe...e new threat is easily picked up in fitness center...sed the overall burden of MRSA within hospitals, t...
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
(Date:11/23/2009)... than 160 participants gathered this week for the ...TIATIVE conference. This year,s topic, "Synthetic ...and medical researchers to explore the engineering...erging field of synthetic biology. , Bonnie L. B...n University and this year,s conference chair, cha...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2AbbeyMoor Medical Receives FDA Approval for Design Improvements to The Spanner 28TM 29 Prostatic Stent 50785 1CareMedic and Cincom Sign OEM Technology Partnership for Healthcare Solution 50783 1CareMedic and Cincom Sign OEM Technology Partnership for Healthcare Solution 50783 2Research Reveals Clues to Breast Cancers Spread 50781 1Research Reveals Clues to Breast Cancers Spread 50781 2...With an incredible lifespan of up to 250 years the...ng the longest-lived of all animals, but how it ob...- to keep going for this long has been a mystery. ...ss online journal PLoS Biology, Erik Cordes and co...waste sulfate not up into the ocean but down into ...
...For the first time, scientists have replicated hep...y to replicate HCV in cell culture will allow rese... of this virus and to test potential antiviral com...ver disease that results from infection with HCV. ...nd Digestive and Kidney Diseases (NIDDK), one of t...
...When the most common adult leukemia in the United ...l of Medicine (NEJM) in 1995, it was seen through ... As such, the journal recently invited three of th...leukemia (CLL) to write an authoritative update co...ity,s knowledge of CLL that has occurred over the ...
Other Biology News: The secret to longevity in tubeworms 2Scientists Replicate Hepatitis C Virus in Laboratory 2Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine 2Gtporator (4 ml) from GEN-TREND s.r.o.
UltraClean Plant DNA Isolation Kit from Mo Bio Laboratories, Inc.
Acridine orange, hemizinc salt from Research Organics, Inc.
Agarose, medium EEO, Molecular Biology Grade from Research Organics, Inc.
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |